Showing results (31-40 of 58) with videos related to
Sort By:
Pageof 6
Nature Cell Biology|December 7, 2010
CDK1-dependent phosphorylation of EZH2 suppresses methylation of H3K27 and promotes osteogenic differentiation of human mesenchymal stem cellsYongkun Wei, Ya-Huey Chen, Long-Yuan Li, et al.Anticancer Research|November 14, 2013
Significant association of caveolin-1 (CAV1) genotypes with upper urothelial tract cancerWen-Shin Chang, Song-Shei Lin, Fang-Jing Li, et al.Annals of Hematology|January 20, 2018
Total body irradiation tremendously impair the proliferation, differentiation and chromosomal integrity of bone marrow-derived mesenchymal stromal stem cellsWen-Jyi Lo, Chiao-Lin Lin, Yu-Chien Chang, et al.Cells|November 27, 2021
Comparative Analyses of Single-Cell Transcriptomic Profiles between In Vitro Totipotent Blastomere-like Cells and In Vivo Early Mouse Embryonic CellsPo-Yu Lin, Denny Yang, Chi-Hsuan Chuang, et al.Journal of Surgical Oncology|September 3, 2013
Clinical and pathologic risk factors of tumor recurrence in patients with node-negative early breast cancer after mastectomyPo-Han Lin, Ming-Hsin Yeh, Liang-Chih Liu, et al.Proceedings of the National Academy of Sciences of the United States of America|August 31, 2010
RNA helicase A is a DNA-binding partner for EGFR-mediated transcriptional activation in the nucleusLongfei Huo, Ying-Nai Wang, Weiya Xia, et al.Biochemical and Biophysical Research Communications|November 25, 2010
Acetylation of EGF receptor contributes to tumor cell resistance to histone deacetylase inhibitorsHui Song, Chia-Wei Li, Adam M Labaff, et al.Anticancer Research|December 16, 2014
Safety and efficacy of pegylated liposomal doxorubicin-based adjuvant chemotherapy in patients with stage I-III triple-negative breast cancerMing-Yu Lien, Liang-Chih Liu, Hwei-Chung Wang, et al.Nature Cell Biology|January 25, 2011
Crosstalk between Arg 1175 methylation and Tyr 1173 phosphorylation negatively modulates EGFR-mediated ERK activationJung-Mao Hsu, Chun-Te Chen, Chao-Kai Chou, et al.Neoplasia (New York, N.Y.)|November 3, 2020
miR-524-5p reduces the progression of the BRAF inhibitor-resistant melanomaMai-Huong Thi Nguyen, Chen-Huan Lin, Szu-Mam Liu, et al.Pageof 6